COMMUNIQUÉS West-GlobeNewswire

Essilor : Nombre total de droits de vote et d'actions composant le capital social au 30 juin 2017
05/07/2017
Nombre total de droits de vote et d'actions composant le capital social au 30 juin 2017 (Article L.233-8 II du Code de Commerce et les articles 221-1 et 223-16 du Règlement Général de l'AMF) Charenton-le-Pont, France ( [...]
Essilor: Disclosure of Share Capital and Voting Rights Outstanding as of June 30, 2017
05/07/2017
Disclosure of Share Capital and Voting Rights Outstanding as of June 30, 2017 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des [...]
Deinove : le processus d'industrialisation du programme caroténoïdes entre en phase II
05/07/2017
DEINOVE : LE PROCESSUS D'INDUSTRIALISATION DU PROGRAMME CAROTÉNOÏDES ENTRE EN PHASE II La Phase I du programme a permis de sélectionner la première molécule caroténoïde qui sera produite à échelle industrielle courant [...]
Deinove: the industrialization process of the carotenoids program enters phase II
05/07/2017
DEINOVE: THE INDUSTRIALIZATION PROCESS OF THE CAROTENOIDS PROGRAM ENTERS PHASE II Phase I of the program selected the first carotenoid molecule to be produced on an industrial scale in 2018. The yields obtained in 20- [...]
Solon Eiendom ASA - Primary insider notification
05/07/2017
SOLON EIENDOM ASA STOCK EXCHANGE ANNOUNCEMENT Solon Eiendom ASA - Primary insider notification (Oslo, Norway, 5 July 2017) Solon Eiendom ASA Board Member Tore Aksel Voldberg (through his wholly owned company Skøien AS) [...]
ProMIS Neurosciences to Present Preclinical Data from Alzheimer's Disease Program at AAIC 2017
05/07/2017
Chief Development Officer Dr. Johanne Kaplan to chair session ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE (AAIC): 16-20 JULY, 2017 LONDON, ENGLAND TORONTO, Ontario and CAMBRIDGE, Massachusetts - July 5, 2017 - [...]
Medibio Appoints Mental Healthcare Advocate and Former Congressman, Patrick Kennedy, to Board of Directors
05/07/2017
SYDNEY, Australia and MINNEAPOLIS, July 05, 2017 (GLOBE NEWSWIRE) -- Australian Stock Exchange listed medical technology company Medibio Limited (MEB or the Company) is pleased to announce the appointment of The [...]
Auris Medical Completes Enrollment of Phase 3 HEALOS Trial of AM-111 for the Treatment of Sudden Deafness
05/07/2017
Top-line results from the HEALOS trial are expected in the fall of 2017 Zug, Switzerland, July 5, 2017 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that [...]
ProQR's Drug Candidate QRX-411 for Usher Syndrome Receives Orphan Drug Designation from FDA and EMA
05/07/2017
Key Updates ProQR's QRX-411 receives Orphan Drug Designation by the FDA and EMA for the treatment of retinitis pigmentosa, including Usher syndrome, the subtype targeted by QRX-411. Usher syndrome is an inherited [...]
Publishing of Orion Corporation's Half-Yearly Report for January-June 2017 on 19 July 2017
05/07/2017
ORION CORPORATION PRESS RELEASE 5 JULY 2017 at 12.15 EEST Publishing of Orion Corporation's Half-Yearly Report for January-June 2017 on 19 July 2017 Orion will publish its Half-Yearly Report for January-June 2017 on [...]
MPI raised SEK 10,3 million in rights issue
05/07/2017
Hoersholm, Denmark, July 5 th, 2017 - Medical Prognosis Institute A/S ("MPI") today announced that approximately SEK 10,3 million before issue costs has been raised. This amount secures financing until H2 2018. A total [...]
Acarix Receives First German Commercial Order For CADScor®System For Early Detection Of Coronary Artery Disease From Private Cardiology Clinic In Berlin
05/07/2017
Malmö, July 5, 2017 Acarix Receives First German Commercial Order For CADScor ® System For Early Detection Of Coronary Artery Disease From Private Cardiology Clinic In Berlin Commercialization program on track as [...]
IBA SA : IBA signe un contrat pour l'installation d'un centre de protonthérapie en Virginie, États-Unis
05/07/2017
IBA signe un contrat pour l'installation d'un centre de protonthérapie en Virginie, États-Unis Contrat signé avec Inova Health Care Services pour l'installation d'une solution Proteus ® PLUS avec deux salles de [...]
IBA SA : IBA to Install Proton Therapy Center in Virginia, USA
05/07/2017
IBA to Install Proton Therapy Center in Virginia, USA Contract signed with Inova Health Care Services for two-room Proteus ® PLUS* proton therapy system near IBA's North American Headquarters Reston, VA, USA, July 5 th [...]
New Phase 2 study with filgotinib in non-infectious uveitis
05/07/2017
Mechelen, Belgium; 5 July 2017; 7.30 CET - Galapagos NV (Euronext & NASDAQ: GLPG) announces a new Phase 2 study investigating filgotinib in non-infectious uveitis, being led by filgotinib collaboration partner [...]
ESPERITE (ESP): L1 Capital subscribes to the fourth packed tranche of investment today
05/07/2017
Zutphen, The Netherlands, 5 July 2017 Esperite N.V. (Euronext: ESP, "Esperite" or "the Group") announces that today a fourth Packed Tranche of EUR 250,000 is issued as a private placement of 25 convertible notes (the " [...]
NEOVACS ANNOUNCES LICENSE AGREEMENT FOR IFNalpha KINOID FOR TREATMENT OF LUPUS IN TURKEY
05/07/2017
PRESS RELEASE · PRESS RELEASE · PRESS RELEASE NEOVACS ANNOUNCES LICENSE AGREEMENT FOR IFNalpha KINOID FOR TREATMENT OF LUPUS IN TURKEY Agreement grants Centurion Pharma exclusive license to market IFNalpha Kinoid in [...]
NEOVACS ANNONCE LA SIGNATURE D'UN ACCORD DE LICENCE POUR L'IFNalpha KINOIDE DANS LE TRAITEMENT DU LUPUS EN TURQUIE
05/07/2017
COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE NEOVACS ANNONCE LA SIGNATURE D'UN ACCORD DE LICENCE POUR L'IFNalpha KINOIDE DANS LE TRAITEMENT DU LUPUS EN TURQUIE Dans le cadre de cet accord, [...]
IBA SA : IBA Déclaration Intermédiaire
05/07/2017
IBA Déclaration Intermédiaire Une conférence téléphonique au sujet de cette déclaration intermédiaire se tiendra ce jour à 15h CEST, 14h BST, 9h EST. Louvain-La-Neuve, Belgique, le 5 juillet 2017 - IBA (Ion Beam [...]

Pages